Abstract: Currently, since a single treatment standard of benign tumors of liver is not established, many serious outcomes due to the excessive treatment of benign tumors of liver still happen sometimes. We should pay attention to composing the guideline on the treatment for the different types of benign tumors of liver on the basis of the multidisciplinary cooperation and the randomized controlled trials, and achieving the goals of 〖JP3〗an unified standard and the standardized therapy, meanwhile, avoiding the pain and burden of excessive treatment on the patients.